GlobalData Report: Novel Therapies to Revitalize the Neuropathic Pain Treatment Market Landscape by 2022
A new report from research and consulting firm GlobalData forecasts the neuropathic pain market value to increase from $2.58 billion in 2012 to $3.53 billion by 2022
A new report from research and consulting firm GlobalData forecasts the neuropathic pain (NP)—covering painful diabetic neuropathy, postherpetic neuralgia and trigeminal neuralgia—market value to increase from $2.58 billion in 2012 to $3.53 billion by 2022, at a compound annual growth rate of 3.19%.
The report cites the expected launch of seven promising NP treatments before 2022—including Daiichi Sankyo’s DS-5565, Convergence’s CNV-2197944, Grünenthal’s Cebranopadol and Impax’s Eladur—and the expected sales of these pipeline therapies to account for 23.8% of the global NP market.
GlobalData believes that there are opportunities for companies to enter the NP market through the development of novel drugs, provided that their product offerings target some of these unmet needs.
*PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
